Managers / Q3 2023 · view latest →
WOLVERINE ASSET MANAGEMENT LLC
CIK 0001279891 · 175 W. JACKSON, SUITE 340, CHICAGO, IL, 60064 · 3128844400
Summary
Wolverine Asset Management LLC reported $8.9B in U.S.-listed holdings across 1,865 positions for Q3 2023.
Its largest position, Ati, represents 2.3% of the portfolio.
Compared with Q2 2023, the fund opened 284 new positions and exited 267.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 39.1% · $3.5B
- US DOMESTIC · 37.6% · $3.3B
- Other · 7.6% · $680M
- GLOBAL · 5.5% · $490M
- ETP · 2.4% · $218M
- Other · 7.7% · $687M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ZTO EXPRESS CAYMAN INC | NEW | +92.11M | 92.11M | +$89M | $89M |
| SAREPTA THERAPEUTICS INC | NEW | +74.97M | 74.97M | +$84M | $84M |
| CYTOKINETICS INC | NEW | +89.37M | 89.37M | +$76M | $76M |
| ROYAL CARIBBEAN GROUP | NEW | +33.80M | 33.80M | +$67M | $67M |
| SEA LTD | NEW | +63.13M | 63.13M | +$60M | $60M |
| INFINERA CORP | NEW | +62.50M | 62.50M | +$58M | $58M |
| HALOZYME THERAPEUTICS INC | NEW | +51.19M | 51.19M | +$48M | $48M |
| ALTAIR ENGR INC | NEW | +44.28M | 44.28M | +$47M | $47M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ATI INC | NOTE 3.500% 6/1 | 2.25% | $201M | 74.42M |
| 2 | PDD HOLDINGS INC | NOTE 10/0 | 2.17% | $194M | 84.24M |
| 3 | ENPHASE ENERGY INC | NOTE 3/0 · NOTE 0.250% 3/0 | 1.83% | $163M | 147.08M |
| 4 | ZILLOW GROUP INC | NOTE 1.375% 9/0 · NOTE 0.750% 9/0 | 1.63% | $145M | 122.26M |
| 5 | ASCENDIS PHARMA A/S | NOTE 2.250% 4/0 | 1.44% | $129M | 139.63M |
| 6 | LI AUTO INC | NOTE 0.250% 5/0 | 1.39% | $124M | 87.84M |
| 7 | DRAFTKINGS INC NEW | NOTE 3/1 | 1.26% | $112M | 147.93M |
| 8 | CONMED CORP | NOTE 2.250% 6/1 | 1.13% | $101M | 105.78M |
| 9 | AIRBNB INC | NOTE 3/1 | 1.01% | $90M | 102.09M |
| 10 | ZTO EXPRESS CAYMAN INC | NOTE 1.500% 9/0 | 1.00% | $89M | 92.11M |
| 11 | SAREPTA THERAPEUTICS INC | NOTE 1.250% 9/1 | 0.94% | $84M | 74.97M |
| 12 | CYTOKINETICS INC | NOTE 3.500% 7/0 | 0.85% | $76M | 89.37M |
| 13 | MACOM TECH SOLUTIONS HLDGS I | NOTE 0.250% 3/1 | 0.77% | $68M | 59.94M |
| 14 | INSMED INC | NOTE 0.750% 6/0 | 0.76% | $68M | 68.31M |
| 15 | SNAP INC | NOTE 0.750% 8/0 | 0.76% | $67M | 76.72M |
| 16 | ROYAL CARIBBEAN GROUP | NOTE 6.000% 8/1 | 0.75% | $67M | 33.80M |
| 17 | SEA LTD | NOTE 2.375%12/0 | 0.68% | $60M | 63.13M |
| 18 | INFINERA CORP | NOTE 3.750% 8/0 | 0.65% | $58M | 62.50M |
| 19 | NATERA INC | NOTE 2.250% 5/0 | 0.61% | $54M | 40.70M |
| 20 | LUMENTUM HLDGS INC | NOTE 0.500%12/1 | 0.60% | $54M | 63.68M |
| 21 | PAGERDUTY INC | NOTE 1.250% 7/0 | 0.59% | $53M | 55.03M |
| 22 | SHIFT4 PMTS INC | NOTE 12/1 | 0.54% | $48M | 48.72M |
| 23 | AAPLAPPLE INChistory → | COM | 0.54% | $48M | 280.9K |
| 24 | HALOZYME THERAPEUTICS INC | NOTE 1.000% 8/1 | 0.54% | $48M | 51.19M |
| 25 | ALTAIR ENGR INC | NOTE 1.750% 6/1 | 0.53% | $47M | 44.28M |
| 26 | INNOVIVA INC | NOTE 2.500% 8/1 | 0.52% | $46M | 46.36M |
| 27 | PERFICIENT INC | NOTE 0.125%11/1 | 0.50% | $45M | 55.35M |
| 28 | NIO INC | NOTE 4.500% 2/0 | 0.50% | $44M | 39.77M |
| 29 | RBC BEARINGS INC | 5% CNV PFD SR A | 0.49% | $43M | 393.2K |
| 30 | CARNIVAL CORP | NOTE 5.750%10/0 | 0.48% | $43M | 28.70M |
| 31 | SPDR S&P 500 ETF TR | TR UNIT | 0.48% | $43M | 100.2K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $10.4B | 1,678 | May 4, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $12.7B | 1,648 | Feb 2, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $13.5B | 1,591 | Oct 28, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $10.8B | 1,599 | Aug 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $8.4B | 1,552 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $10.0B | 1,610 | Feb 3, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $9.3B | 1,643 | Nov 4, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $8.8B | 1,653 | Aug 1, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $8.7B | 1,657 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $11.7B | 1,775 | Feb 1, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $8.9B | 1,865 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $8.4B | 1,794 | Aug 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $8.5B | 1,858 | May 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $9.7B | 2,104 | Feb 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $9.3B | 2,532 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $10.0B | 2,450 | Aug 3, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $10.2B | 2,236 | May 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $10.7B | 2,084 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $11.6B | 2,037 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $13.1B | 2,153 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $11.8B | 2,004 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $13.6B | 1,629 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $11.3B | 1,565 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $10.0B | 1,525 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $6.9B | 1,442 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $8.6B | 1,351 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $7.9B | 1,384 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $7.7B | 1,388 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $7.3B | 1,349 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $8.3B | 1,602 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- Wolverine Holdings, L.P.028-17506
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.